Works matching IS 03407004 AND DT 2019 AND VI 68 AND IP 2

Results: 15

Can benign lymphoid tissue changes in <sup>18</sup>F-FDG PET/CT predict response to immunotherapy in metastatic melanoma?

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 2, p. 297, doi. 10.1007/s00262-018-2279-9

By:

Sachpekidis, Christos;
Larribère, Lionel;
Kopp-Schneider, Annette;
Hassel, Jessica C.;
Dimitrakopoulou-Strauss, Antonia

Publication type:

Article

Tumor-infiltrating immune cell subpopulations and programmed death ligand 1 (PD-L1) expression associated with clinicopathological and prognostic parameters in ependymoma.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 2, p. 305, doi. 10.1007/s00262-018-2278-x

By:

Nam, Soo Jeong;
Kim, Young-Hoon;
Park, Ji Eun;
Ra, Young-shin;
Khang, Shin Kwang;
Cho, Young Hyun;
Kim, Jeong Hoon;
Sung, Chang Ohk

Publication type:

Article

Upregulation of tumor PD-L1 by neoadjuvant chemoradiotherapy (neoCRT) confers improved survival in patients with lymph node metastasis of locally advanced rectal cancers.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 2, p. 283, doi. 10.1007/s00262-018-2275-0

By:

Chiang, Shu-Fen;
Huang, Chih-Yang;
Ke, Tao-Wei;
Chen, Tsung-Wei;
Lan, Yu-Ching;
You, Ying-Shu;
Chen, William Tzu-Liang;
Chao, K. S. Clifford

Publication type:

Article

Hyperresponsiveness to interferon gamma exposure as a response mechanism to anti-PD-1 therapy in microsatellite instability colorectal cancer.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 2, p. 257, doi. 10.1007/s00262-018-2270-5

By:

Yuan, Wenli;
Deng, Deyao;
Jiang, Hongchao;
Tu, Changling;
Shang, Xueqin;
He, Hongchun;
Niu, Ruize;
Dong, Jian

Publication type:

Article

The expression of MHC class II molecules on murine breast tumors delays T-cell exhaustion, expands the T-cell repertoire, and slows tumor growth.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 2, p. 175, doi. 10.1007/s00262-018-2262-5

By:

McCaw, Tyler R.;
Li, Mei;
Starenki, Dmytro;
Cooper, Sara J.;
Liu, Mingyong;
Meza-Perez, Selene;
Arend, Rebecca C.;
Buchsbaum, Donald J.;
Forero, Andres;
Randall, Troy D.

Publication type:

Article

A phase I clinical study of a cocktail vaccine of Wilms' tumor 1 (WT1) HLA class I and II peptides for recurrent malignant glioma.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 2, p. 331, doi. 10.1007/s00262-018-2274-1

By:

Tsuboi, Akihiro;
Hashimoto, Naoya;
Fujiki, Fumihiro;
Morimoto, Soyoko;
Kagawa, Naoki;
Nakajima, Hiroko;
Hosen, Naoki;
Nishida, Sumiyuki;
Nakata, Jun;
Morita, Satoshi;
Sakamoto, Junichi;
Oji, Yusuke;
Oka, Yoshihiro;
Sugiyama, Haruo

Publication type:

Article

Analysis of tumor-infiltrating CD103 resident memory T-cell content in recurrent laryngeal squamous cell carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 2, p. 213, doi. 10.1007/s00262-018-2256-3

By:

Mann, Jacqueline E.;
Smith, Joshua D.;
Birkeland, Andrew C.;
Bellile, Emily;
Swiecicki, Paul;
Mierzwa, Michelle;
Chinn, Steven B.;
Shuman, Andrew G.;
Malloy, Kelly M.;
Casper, Keith A.;
McLean, Scott A.;
Moyer, Jeffery S.;
Wolf, Gregory T.;
Bradford, Carol R.;
Prince, Mark E.;
Carey, Thomas E.;
McHugh, Jonathan B.;
Spector, Matthew E.;
Brenner, J. Chad

Publication type:

Article

Phase 1 study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 2, p. 319, doi. 10.1007/s00262-018-2248-3

By:

Huijts, Charlotte M.;
Werter, Inge M.;
Lougheed, Sinéad M.;
Goedegebuure, Ruben S.;
van Herpen, Carla M.;
Hamberg, Paul;
Tascilar, Metin;
Haanen, John B.;
Verheul, Henk M.;
de Gruijl, Tanja D.;
van der Vliet, Hans J.;
for the Dutch WIN-O Consortium

Publication type:

Article

Inhibitory functions of PD-L1 and PD-L2 in the regulation of anti-tumor immunity in murine tumor microenvironment.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 2, p. 201, doi. 10.1007/s00262-018-2263-4

By:

Umezu, Daisuke;
Okada, Nana;
Sakoda, Yukimi;
Adachi, Keishi;
Ojima, Toshiyasu;
Yamaue, Hiroki;
Eto, Masatoshi;
Tamada, Koji

Publication type:

Article

Targeting the polarization of tumor-associated macrophages and modulating mir-155 expression might be a new approach to treat diffuse large B-cell lymphoma of the elderly.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 2, p. 269, doi. 10.1007/s00262-018-2273-2

By:

Poles, Wagner A.;
Nishi, Erika E.;
de Oliveira, Mariana B.;
Eugênio, Angela I. P.;
de Andrade, Tathiana A.;
Campos, Antonio Hugo F. M.;
de Campos, Ruy R.;
Vassallo, José;
Alves, Antonio C.;
Scapulatempo Neto, Cristovam;
Paes, Roberto Antonio Pinto;
Landman, Gilles;
Zerbini, Maria Cláudia N.;
Colleoni, Gisele W. B.

Publication type:

Article

INT-HA induces M2-like macrophage differentiation of human monocytes via TLR4-miR-935 pathway.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 2, p. 189, doi. 10.1007/s00262-018-2261-6

By:

Zhang, Boke;
Du, Yan;
He, Yiqing;
Liu, Yiwen;
Zhang, Guoliang;
Yang, Cuixia;
Gao, Feng

Publication type:

Article

Development of CDX-1140, an agonist CD40 antibody for cancer immunotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 2, p. 233, doi. 10.1007/s00262-018-2267-0

By:

Vitale, Laura A.;
Thomas, Lawrence J.;
He, Li-Zhen;
O'Neill, Thomas;
Widger, Jenifer;
Crocker, Andrea;
Sundarapandiyan, Karuna;
Storey, James R.;
Forsberg, Eric M.;
Weidlick, Jeffrey;
Baronas, April R.;
Gergel, Lauren E.;
Boyer, James M.;
Sisson, Crystal;
Goldstein, Joel;
Marsh, Henry C.;
Keler, Tibor

Publication type:

Article

The nature of the human T cell response to the cancer antigen 5T4 is determined by the balance of regulatory and inflammatory T cells of the same antigen-specificity: implications for vaccine design.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 2, p. 247, doi. 10.1007/s00262-018-2266-1

By:

Besneux, Matthieu;
Greenshields-Watson, Alexander;
Scurr, Martin J.;
MacLachlan, Bruce J.;
Christian, Adam;
Davies, Michael M.;
Hargest, Rachel;
Phillips, Simon;
Godkin, Andrew;
Gallimore, Awen

Publication type:

Article

Stromal interleukin-33 promotes regulatory T cell-mediated immunosuppression in head and neck squamous cell carcinoma and correlates with poor prognosis.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 2, p. 221, doi. 10.1007/s00262-018-2265-2

By:

Wen, Yi-hui;
Lin, Han-qing;
Li, Hang;
Zhao, Yi;
Lui, Vivian Wai Yan;
Chen, Lin;
Wu, Xing-mei;
Sun, Wei;
Wen, Wei-ping

Publication type:

Article

Histamine targets myeloid-derived suppressor cells and improves the anti-tumor efficacy of PD-1/PD-L1 checkpoint blockade.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 2, p. 163, doi. 10.1007/s00262-018-2253-6

By:

Grauers Wiktorin, Hanna;
Nilsson, Malin S.;
Kiffin, Roberta;
Sander, Frida Ewald;
Lenox, Brianna;
Rydström, Anna;
Hellstrand, Kristoffer;
Martner, Anna

Publication type:

Article